Higher number of CD4+ T cells was observed in patients whose tumor expressed sarcomatoid dedifferentiation, that is commonly associated with an immune-inflamed phenotype characterized by immune activation, upregulation of antigen presentation genes and, finally, good clinical response to immune checkpoint blockade [20]. The gene discussed is CD4; the disease is neoplasm.